Helius Medical Technologies (OTCMKTS:HSDT) was downgraded by investment analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Friday.

Helius Medical Technologies (OTCMKTS:HSDT) traded down $0.05 during trading hours on Friday, reaching $2.23. 16,045 shares of the company were exchanged, compared to its average volume of 90,611. Helius Medical Technologies has a 1-year low of $1.29 and a 1-year high of $4.14.

In other news, Director Blane Walter bought 40,000 shares of the firm’s stock in a transaction on Friday, November 17th. The shares were purchased at an average cost of $2.46 per share, with a total value of $98,400.00. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Dane Andreeff bought 167,000 shares of the firm’s stock in a transaction on Monday, November 13th. The stock was purchased at an average cost of $2.58 per share, for a total transaction of $430,860.00. The disclosure for this purchase can be found here. 39.70% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION WARNING: This article was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/12/02/helius-medical-technologies-hsdt-cut-to-sell-at-valuengine.html.

About Helius Medical Technologies

Helius Medical Technologies, Inc is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device.

Receive News & Stock Ratings for Helius Medical Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies Inc. and related stocks with our FREE daily email newsletter.